Pulse Biosciences, Inc. (PLSE) Stock Grade

About Pulse Biosciences, Inc.'s fundamentals

Pulse Biosciences is a healthcare company with a market capitalization of $925.3 million that operates in the medical instruments and supplies industry. The company reported flat revenue growth year-over-year at 0.0% and posted a significant net loss in its latest annual statement, resulting in a net margin of -20794.6%. With no dividend yield and the company operating unprofitably, traditional profitability metrics like P/E ratio and return on equity are not applicable.